KEGG: ecp:ECP_3331
yceF2 is a bacterial protein found in Escherichia coli strains, particularly O6:K15:H31 (strain 536/UPEC). According to UniProt data, it appears to function as a nucleoside triphosphate pyrophosphatase that hydrolyzes 7-methyl-GTP (m7GTP) . This enzymatic activity suggests a role in RNA metabolism, potentially affecting processes like mRNA cap recognition or degradation.
Similar to the well-characterized YciF protein, yceF2 may play important roles in bacterial stress response . YciF is upregulated when bacteria experience stress conditions and is highly conserved across bacterial species. The crystal structure studies indicate it forms a homodimer with a significant burial of solvent-accessible surface area, featuring an all-alpha protein composition with five helices .
Functional analysis suggests yceF2 may have dual roles in cell division arrest and metabolic regulation during stress conditions, making it an important target for researchers studying bacterial adaptation mechanisms .
Based on product documentation and research literature, yceF2 antibody has been validated for the following applications:
| Application | Validated Use | Recommended Dilution |
|---|---|---|
| ELISA | Detection and quantification | Varies by manufacturer |
| Western Blotting (WB) | Protein expression analysis | Typically 1:1000 |
These techniques enable researchers to:
Detect and quantify yceF2 protein expression in bacterial lysates
Monitor changes in yceF2 levels under various stress conditions
Verify protein knockdown or overexpression in genetic studies
Examine yceF2 distribution in fractionated bacterial samples
The antibody's species reactivity is specifically directed toward bacteria, particularly Escherichia coli O6:K15:H31 (strain 536/UPEC). Cross-reactivity with other bacterial species requires validation for each specific research application .
Optimal detection of yceF2 in bacterial samples requires careful consideration of sample preparation:
Culture conditions:
For stress response studies, expose bacteria to relevant stressors (oxidative, nutrient limitation, pH, temperature) for defined periods
Harvest cells at consistent optical density to control for growth phase effects
Cell lysis optimization:
Use bacterial lysis buffer containing 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1% Triton X-100
Include protease inhibitor cocktail (PMSF, leupeptin, aprotinin) to prevent degradation
For complete lysis, sonication (6 × 10 seconds pulses at 30% amplitude) typically yields better results than chemical lysis alone
Protein extraction considerations:
Centrifuge lysates at 12,000 × g for 20 minutes at 4°C to remove cellular debris
Determine protein concentration using Bradford or BCA assay
Standardize loading to 20-30 μg total protein per lane for Western blotting
For immunofluorescence microscopy applications, fix bacteria with 4% paraformaldehyde for 15 minutes followed by permeabilization with 0.1% Triton X-100, which preserves cellular structures while allowing antibody access to intracellular antigens.
Thorough validation of yceF2 antibody specificity is essential for reliable experimental results. Include the following controls:
Genetic validation:
yceF2 knockout strain as a negative control
Complemented knockout strain expressing wild-type yceF2 as specificity control
Strains with varying expression levels to assess detection sensitivity
Recombinant protein controls:
Purified recombinant yceF2 with different tags (His, GST, MBP)
Run alongside experimental samples to confirm correct molecular weight detection
Create standard curves for quantification purposes
Pre-absorption controls:
Pre-incubate antibody with excess purified yceF2 protein
Should eliminate specific binding, confirming signal specificity
Include in parallel with normal antibody incubation
Cross-reactivity assessment:
Test against lysates from related bacterial species
Include purified proteins with similar sequence homology
Document any non-specific binding patterns
For complete validation, a combination of Western blotting, ELISA, and if possible, mass spectrometry confirmation of immunoprecipitated proteins provides robust evidence of antibody specificity.
To study yceF2 expression changes during stress response:
Experimental design:
Expose bacteria to different stressors (H₂O₂, heat shock, antibiotic stress)
Collect samples at multiple time points (0, 15, 30, 60, 120 minutes)
Include a recovery phase to assess reversibility
Quantitative Western blotting:
Use yceF2 antibody at optimized dilution (typically 1:1000)
Include loading controls (RNA polymerase or GroEL)
Employ fluorescent secondary antibodies for accurate quantification
Analyze with image analysis software (ImageJ with Western blot plugins)
Complementary approaches:
Pair protein detection with RT-qPCR for yceF2 transcript levels
Compare with proteomics data for global stress response context
Use reporter fusions (yceF2-GFP) to monitor expression in living cells
Data analysis:
Calculate fold changes relative to unstressed conditions
Perform statistical analysis across biological replicates
Plot time-course expression changes with appropriate error representation
This approach allows correlation of yceF2 expression patterns with specific stress responses, providing insights into its regulatory mechanisms and functional importance under adverse conditions.
To characterize yceF2 protein interactions:
Co-immunoprecipitation (Co-IP):
Conjugate yceF2 antibody to appropriate resin (Protein A/G or magnetic beads)
Lyse bacteria under gentle conditions to preserve protein complexes
Wash stringently to remove non-specific interactions
Analyze co-precipitated proteins by mass spectrometry or Western blotting
Validate with reverse Co-IP using antibodies against identified partners
Crosslinking-assisted affinity purification:
Treat live bacteria with membrane-permeable crosslinkers (DSP, formaldehyde)
Stabilizes transient interactions before cell disruption
Use yceF2 antibody for immunoprecipitation under denaturing conditions
Reverse crosslinks before final analysis
Bacterial two-hybrid systems:
Generate yceF2 fusion constructs with split reporter proteins
Screen against genomic libraries to identify interaction partners
Validate positive interactions with Co-IP using yceF2 antibody
Proximity-dependent biotin identification (BioID):
Create fusion of yceF2 with promiscuous biotin ligase (BirA*)
Proximal proteins become biotinylated in vivo
Purify using streptavidin and identify by mass spectrometry
Confirm interactions with yceF2 antibody in follow-up experiments
These complementary approaches provide a comprehensive view of the yceF2 interactome under different physiological conditions.
Developing a quantitative ELISA requires careful optimization:
Assay design options:
Direct ELISA: Immobilize bacterial lysate, detect with yceF2 antibody
Sandwich ELISA: Use capture antibody (e.g., anti-His if recombinant protein available), then detect with yceF2 antibody
Competitive ELISA: Pre-mix samples with labeled yceF2, measure displacement from antibody
Protocol optimization:
Coating buffer: 0.1 M carbonate buffer (pH 9.6) typically works well
Blocking: 3% BSA in PBS to minimize background
Sample preparation: Standardized lysis protocol for consistent results
Antibody dilution: Titrate to determine optimal concentration (typically 1:500-1:2000)
Detection system: HRP-conjugated secondary antibody with TMB substrate
Standard curve preparation:
Use purified recombinant yceF2 protein
Prepare fresh dilution series (0.1-100 ng/mL)
Include on each plate to account for inter-assay variation
Validation:
Spike-recovery experiments to assess matrix effects
Precision assessment (intra- and inter-assay coefficients of variation)
Sensitivity determination (limit of detection, limit of quantification)
| Component | Recommended Condition | Notes |
|---|---|---|
| Coating | 2-5 μg/mL protein in carbonate buffer | Overnight at 4°C |
| Blocking | 3% BSA in PBS | 1 hour at room temperature |
| Primary Antibody | yceF2 antibody (1:1000) | 2 hours at room temperature |
| Secondary Antibody | HRP-conjugated anti-rabbit IgG (1:5000) | 1 hour at room temperature |
| Substrate | TMB solution | 10-15 minutes development |
This standardized ELISA allows precise quantification of yceF2 across different experimental conditions.
To establish relationships between protein expression and function:
Synchronized sample collection:
Divide bacterial cultures into aliquots for parallel analyses
Process samples under identical conditions to minimize variability
Include multiple growth phases (lag, exponential, stationary)
Protein quantification methods:
Quantitative Western blotting using yceF2 antibody with calibration standards
ELISA for high-throughput quantification across multiple samples
Mass spectrometry with labeled peptide standards for absolute quantification
Enzymatic activity assessment:
Develop assays for 7-methyl-GTP hydrolysis using HPLC detection
Monitor phosphate release using colorimetric methods (malachite green)
Ensure linear range of detection for accurate quantification
Control for potential inhibitors in bacterial lysates
Data integration:
Plot enzyme activity against protein levels
Calculate specific activity (enzyme activity/protein amount)
Identify conditions where post-translational modifications might affect activity
This correlation analysis can reveal regulatory mechanisms that modulate yceF2 function independently of expression levels, such as protein-protein interactions or post-translational modifications.
For successful immunolocalization studies:
Sample preparation protocol:
Grow bacteria to desired phase/condition
Fix with 4% paraformaldehyde (15 minutes, room temperature)
Wash thoroughly with PBS (3 × 5 minutes)
Permeabilize with 0.1% Triton X-100 (5 minutes)
Block with 3% BSA in PBS (1 hour)
Immunostaining procedure:
Primary incubation: yceF2 antibody (1:100-1:500 dilution, overnight at 4°C)
Wash thoroughly (3 × 5 minutes with PBS)
Secondary incubation: fluorophore-conjugated anti-rabbit IgG (1:500, 1 hour)
Counterstain with DAPI (1 μg/mL, 5 minutes) for nucleoid visualization
Mount using anti-fade mounting medium
Advanced imaging approaches:
Confocal microscopy for precise localization and 3D reconstruction
Super-resolution techniques (STORM, STED) for sub-diffraction resolution
Time-lapse imaging with physiological triggers to observe dynamic changes
Quantitative analysis:
Measure fluorescence intensity across cell length
Calculate colocalization coefficients with organelle markers
Perform population-level analysis of localization patterns
Include appropriate controls (no primary antibody, pre-immune serum, competitive inhibition with recombinant protein) to validate specificity of the observed localization patterns.
For host-pathogen interaction studies:
Infection model selection:
Cell line models: Uroepithelial cells for UPEC studies
Primary cell models: Higher physiological relevance but greater variability
3D organoid cultures: Mimic tissue architecture for more complex interactions
Experimental design factors:
Bacterial preparation: Growth phase and media affect virulence factor expression
MOI standardization: Consistent infection levels for reproducible results
Time course: Multiple timepoints to capture different infection stages
Gentamicin protection assay: Distinguish between adherent and internalized bacteria
Sample processing optimization:
Fixation protocols that preserve both host and bacterial antigens
Sequential permeabilization: Gentle for host cells, stronger for bacteria
Blocking with normal serum from secondary antibody species plus BSA
Analytical approaches:
Confocal microscopy: Co-stain with markers for subcellular compartments
Flow cytometry: Quantify bacterial populations with different expression levels
Biochemical fractionation: Separate host cytosolic, membrane, and nuclear fractions
Transcriptomics: Correlate yceF2 expression with host response genes
Controls and validation:
Uninfected cells as negative controls
Heat-killed bacteria to distinguish active processes
Isogenic yceF2 mutants to establish functional significance
This comprehensive approach allows researchers to dissect the role of yceF2 in bacterial pathogenesis and host response mechanisms.
When encountering detection issues:
| Problem | Possible Causes | Troubleshooting Steps |
|---|---|---|
| No signal | Insufficient protein | Increase sample loading (30-50 μg) |
| Inefficient transfer | Optimize transfer conditions for protein size | |
| Antibody degradation | Use fresh antibody aliquot | |
| Low expression level | Enrich target by immunoprecipitation before blotting | |
| Weak signal | Suboptimal antibody dilution | Titrate antibody concentration (try 1:500) |
| Insufficient incubation time | Extend primary antibody incubation to overnight at 4°C | |
| Inadequate blocking | Test alternative blocking agents (5% milk, commercial blockers) | |
| Detection system sensitivity | Switch to more sensitive substrate (ECL Plus, SuperSignal West Femto) | |
| High background | Insufficient washing | Increase wash duration and volume (4-5 × 10 minutes) |
| Non-specific binding | Add 0.1% Tween-20 to antibody dilution buffer | |
| Cross-reactivity | Try alternative blocking agents or increase blocking time |
For bacterial samples specifically:
Optimize lysis method (sonication often works better than detergent-based lysis)
Include lysozyme (1 mg/mL) in lysis buffer to improve cell wall disruption
Process samples promptly to minimize proteolysis
Consider urea-based lysis (8M urea) for difficult-to-extract proteins
These systematic troubleshooting approaches can help resolve common issues when working with yceF2 antibody.
To investigate post-translational modifications (PTMs):
Sequential immunoprecipitation strategy:
First IP: Use yceF2 antibody to isolate total yceF2 protein
Second IP: Use antibodies against specific PTMs (phospho, acetyl, ubiquitin)
Alternatively, use PTM antibodies first, then detect yceF2 by Western blot
2D gel electrophoresis approach:
Separate proteins by isoelectric point and molecular weight
Perform Western blot with yceF2 antibody
Multiple spots indicate different PTM states
Compare patterns under different conditions
Mass spectrometry workflow:
Immunoprecipitate yceF2 using specific antibody
Perform tryptic digest and analyze by LC-MS/MS
Search for modification-specific mass shifts
Quantify relative abundance of modified peptides
Phosphorylation-specific analysis:
Treat samples with phosphatase before Western blotting
Compare migration patterns with and without treatment
Use Phos-tag gels for enhanced separation of phosphorylated forms
Combine with phospho-specific stains (Pro-Q Diamond)
These complementary approaches provide comprehensive characterization of PTMs that may regulate yceF2 function under different physiological conditions.
If yceF2 is suspected to have DNA-binding capabilities:
Bacterial ChIP protocol optimization:
Cross-linking: 1% formaldehyde for 10-15 minutes at room temperature
Quenching: 125 mM glycine for 5 minutes
Lysis: Enzymatic (lysozyme) followed by sonication
Sonication optimization: 10-15 cycles (30s ON/30s OFF) to yield 200-500 bp fragments
Verify fragmentation efficiency by agarose gel electrophoresis
Immunoprecipitation procedure:
Pre-clear chromatin with Protein A/G beads
Incubate with yceF2 antibody (5-10 μg per IP) overnight at 4°C
Capture complexes with fresh Protein A/G beads
Wash stringently to remove non-specific binding
Elute and reverse cross-links (65°C overnight)
Treat with RNase A and Proteinase K
Purify DNA using column-based methods
Controls and validation:
Input sample (non-immunoprecipitated chromatin)
Mock IP (no antibody or pre-immune serum)
Positive control (antibody against known DNA-binding protein)
qPCR validation of selected targets before sequencing
Data analysis pipeline:
Align reads to reference genome
Peak calling using MACS2 or similar algorithms
Motif discovery with MEME suite
Functional annotation of bound regions
This approach enables genome-wide identification of potential yceF2 binding sites, providing insights into its potential role in transcriptional regulation.
To investigate yceF2's role in stress resistance:
Expression correlation studies:
Expose bacteria to various stressors (oxidative, pH, temperature, antibiotics)
Collect samples at multiple timepoints
Quantify yceF2 levels by Western blot or ELISA
Correlate expression with survival rates
Cellular localization changes:
Perform immunofluorescence under normal and stress conditions
Analyze potential relocalization events
Co-stain with markers for stress response components
Quantify changes in distribution patterns
Protein-protein interaction dynamics:
Compare yceF2 interactome under normal vs. stress conditions
Use antibody for co-IP followed by mass spectrometry
Look for stress-specific interaction partners
Validate key interactions by reciprocal co-IP
Functional impact assessment:
Generate yceF2 deletion and complementation strains
Compare stress tolerance phenotypes
Measure enzymatic activity using biochemical assays
Correlate protein levels with functional readouts
Combined with transcriptomics and phenotypic assays, these approaches can elucidate yceF2's mechanistic role in bacterial stress adaptation.
For drug discovery applications:
Assay design options:
Expression-based: Monitor yceF2 levels by ELISA after compound treatment
Activity-based: Couple enzymatic activity to antibody detection
Localization-based: Automated imaging of yceF2 distribution changes
ELISA-based screening protocol:
Grow bacteria in 96-well format with compound libraries
Lyse cells directly in plates using optimized buffer
Transfer lysates to antibody-coated plates
Detect using HRP-conjugated secondary antibody
Include positive/negative controls on each plate
Assay optimization requirements:
Determine Z' factor for assay quality assessment
Establish dose-response relationships with control compounds
Optimize incubation times and washing steps for automation
Develop data normalization approaches
Secondary validation assays:
Western blotting confirmation of hits
Enzymatic activity measurement
Bacterial growth/survival assessment
Target engagement validation
This approach enables large-scale screening for compounds that modulate yceF2 expression or function, potentially identifying new antimicrobial strategies targeting bacterial stress response mechanisms.